Patent · US Active

C3B binding polypeptide

US11524050B2 · kind B2 · utility

1Cited by

5References

23Claims

0Family size

Assignee

Complement Therapeutics Limited · GB

Inventors

Paul D. Bishop · Fall City, US
Simon Clark · San Mateo, US
Richard Unwin · London, GB

Key dates

Filing date	Jan 15, 2019
Grant date	Dec 13, 2022
Priority date	—
Expiry date	Jan 15, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed are uses and methods using the polypeptides for treating and preventing diseases and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.